On August 2nd, Gelunhui reported that Youcare Pharmaceutical Group (688658.SH) received the "Drug Supplement Application Approval Notice" (Notice No. 2024B03474) issued by the State Drug Administration for Cefradine Capsules (Specification: 0.25g). The drug has passed the evaluation of consistency in quality and efficacy of generic drugs.
Cefradine Capsules are mainly used for respiratory tract infections such as acute pharyngitis, tonsillitis, otitis media, bronchitis, pneumonia caused by sensitive bacteria, urinary and reproductive tract infections, and skin and soft tissue infections. This drug is an oral preparation and should not be used for severe infections.
